FNV.TO (FNV.TO)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 62.8. Beneish M-Score of -1.99 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency is robust, evidenced by an ROIC of 13.8% that suggests the firm generates returns exceeding typical cost of equity thresholds. The DuPont decomposition reveals a margin-driven growth engine where exceptional net margins at 61.0%, fueled by gross profitability near 74%, outweigh modest asset turnover of 0.22x and conservative leverage with an equity multiplier of just over 1.08x. Financial integrity metrics reinforce this quality profile; the Altman Z-Score of 62.8 indicates a negligible probability of bankruptcy, while a Beneish M-Score of -1.99 signals strong evidence against earnings manipulation. Additionally, a Piotroski F-Score of 6/9 reflects solid fundamental stability without recent deterioration in profitability or leverage ratios.
Valuation multiples currently trade at a significant premium relative to historical norms and sector peers, with the P/E ratio expanding to 40.8x. This multiple appears to price in aggressive future expansion, as implied by revenue growth accelerating 63.7% year-over-year; however, such high valuations typically compress margins if growth momentum decelerates or operating costs rise disproportionately against top-line gains. The market is effectively demanding a sustained continuation of this hyper-growth trajectory to justify the current cost basis, leaving little room for error in execution.
Insider flow remains neutral over the preceding 90 days with zero net activity, offering no directional signal from management regarding near-term capital deployment or sentiment shifts. While the fundamental economics display high-quality characteristics and low distress risk, the valuation gap between current pricing and historical averages introduces a notable downside sensitivity should growth rates normalize below market expectations.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
FNV.TO Capital Efficiency
How efficiently does FNV.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
FNV.TO converts -41% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 141% reinvestment rate signals aggressive capacity expansion.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare FNV.TO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.